Membrane Cholesterol: Implications in Receptor Function

Cholesterol Regulation of Ion Channels and Receptors

Volumn , Issue , 2012, Pages 255-271

  Shrivastava, Sandeep ^a   Chattopadhyay, Amitabha ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

Cholesterol depletion and statins, chronic depletion on human serotonin1A; Cholesterol structure, membrane, GPCRs as target for novel drug candidates; Membrane cholesterol, implications in receptor function; Specialized domains, membrane cholesterol in host pathogen interactions; Structure and orientation of cholesterol, nonrandom distribution in domains

Indexed keywords

EID: 84873095443     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118342312.ch12     Document Type: Chapter

References (87)

1. Adamian L, Naveed H, Liang J. Lipid-binding surfaces of membrane proteins: evidence from evolutionary and structural analysis. Biochim Biophys Acta 2011;1808: 1092-1102.
2. Beasley CL, Honer WG, Bergmann K, Falkai P, Lütjohann D, Bayer TA. Reductions in cholesterol and synaptic markers in association cortex in mood disorders. Bipolar Disord 2005;7:449-455.
3. Bloch KE. Sterol structure and membrane function. CRC Crit Rev Biochem 1983;14: 47-92.
4. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986;232:34-47.
5. Burger K, Gimpl G, Fahrenholz F. Regulation of receptor function by cholesterol. Cell Mol Life Sci 2000;57:1577-1592.
6. Chambers CM, McLean MP, Ness GC. Smith-Lemli-Opitz syndrome produced in rats with AY 9944 treated by intravenous injection of lipoprotein cholesterol. Am J Med Genet 1997;68:322-327.
7. Chattopadhyay A, Paila YD. Lipid-protein interactions, regulation and dysfunction of brain cholesterol. Biochem Biophys Res Commun 2007;354:627-633.
8. Chaudhuri A, Chattopadhyay A. Transbilayer organization of membrane cholesterol at low concentrations: implications in health and disease. Biochim Biophys Acta 2011;1808:19-25.
9. Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SGF, Thian FS, Kobilka TS, Choi H-J, Kuhn P, Weis WI, Kobilka BK, Stevens RC. High-resolution crystal structure of an engineered human ß2-adrenergic G protein-coupled receptor. Science 2007;318: 1258-1265.
10. Engelman DM. Membranes are more mosaic than fluid. Nature 2005;438:578-580. Epand RM. Cholesterol and the interaction of proteins with membrane domains. Prog Lipid Res 2006;45:279-294.
11. Epand RM. Cholesterol and the interaction of proteins with membrane domains. Prog Lipid Res 2006;45:279-294.
12. Epand RM, Sayer BG, Epand RF. Caveolin scaffolding region and cholesterol-rich domains in membranes. J Mol Biol 2005;345:339-350.
13. Fantini J, Barrantes FJ. Sphingolipid/cholesterol regulation of neurotransmitter receptor conformation and function. Biochim Biophys Acta 2009;1788:2345-2361.
14. Galea AM, Brown AJ. Special relationship between sterols and oxygen: were sterols an adaptation to aerobic life? Free Radic Biol Med 2009;47:880-889.
15. Ganguly S, Chattopadhyay A. Cholesterol depletion mimics the effect of cytoskeletal destabilization on membrane dynamics of the serotonin1A receptor: a zFCS study. Biophys J 2010;99:1397-1407.
16. Gaoua W, Wolf C, Chevy F, Ilien F, Roux C. Cholesterol deficit but not accumulation of aberrant sterols is the major cause of the teratogenic activity in the Smith-Lemli-Opitz syndrome animal model. J Lipid Res 2000;41:637-646.
17. Gardier AM. Mutant mouse models and antidepressant drug research: focus on serotonin and brain-derived neurotrophic factor. Behav Pharmacol 2009;20:18-32.
18. Gatfield J, Pieters J. Essential role for cholesterol in entry of Mycobacteria into macrophages. Science 2000;288:1647-1650.
19. Gimpl G. Cholesterol-protein interaction: methods and cholesterol reporter molecules. Subcell Biochem 2010;51:1-45.
20. Goluszko P, Nowicki B. Membrane cholesterol: a crucial molecule affecting interactions of microbial pathogens with mammalian cells. Infect Immun 2005;73:7791-7796.
21. Hanson MA, Cherezov V, Griffith MT, Roth CB, Jaakola V-P, Chien EYT, Velasquez J, Kuhn P, Stevens RC. A specific cholesterol binding site is established by the 2.8 °A structure of the human ß2-adrenergic receptor. Structure 2008;16:897-905.
22. Harrison T, Samuel BU, Akompong T, Hamm H, Mohandas N, Lomasney JW, Haldar K. Erythrocyte G protein-coupled receptor signaling in malarial infection. Science 2003; 301:1734-1736.
23. Heilker R, Wolff M, Tautermann CS, Bieler M. G-protein-coupled receptor-focused drug discovery using a target class platform approach. Drug Discov Today 2009;14: 231-240.
24. Incardona JP, Eaton S. Cholesterol in signal transduction. Curr Opin Cell Biol 2000;12:193-203.
25. Irons M, Elias ER, Salen G, Tint GS, Batta AK. Defective cholesterol biosynthesis in Smith-Lemli-Opitz Syndrome. Lancet 1993;341:1414.
26. Istvan ES, Deisenhofer J. Structural mechanism for statin inhibition of HMG-CoA reductase. Science 2002;292:1160-1164.
27. Jafurulla M, Tiwari S, Chattopadhyay A. Identification of cholesterol recognition amino acid consensus (CRAC) motif in G-protein coupled receptors. Biochem Biophys Res Commun 2011;404:569-573.
28. Kalipatnapu S, Chattopadhyay A. Membrane organization of the human serotonin1A receptor monitored by detergent insolubility using GFP fluorescence. Mol Membr Biol 2005;22:539-547.
29. Kalipatnapu S, Chattopadhyay A. Membrane organization and function of the serotonin1A receptor. Cell Mol Neurobiol 2007;27:1097-1116.
30. Lange Y, Steck TL. Cholesterol homeostasis and the escape tendency (activity) of plasma membrane cholesterol. Prog Lipid Res 2008;47:319-332.
31. Lauer S, VanWye J, Harrison T, McManus H, Samuel BU, Hiller NL, Mohandas N, Haldar K. Vacuolar uptake of host components, and a role for cholesterol and sphingomyelin in malarial infection. EMBO J 2000;19:3556-3564.
32. Lee AG. How lipids affect the activities of integral membrane proteins. Biochim Biophys Acta 2004;1666:62-87.
33. Li H, Papadopoulos V. Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern. Endocrinology 1998;139:4991-4997.
34. Li H, Yao Z-X, Degenhardt B, Teper G, Papadopoulos V. Cholesterol binding at the cholesterol recognition/interaction amino acid consensus (CRAC) of the peripheraltype benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide. Proc Natl Acad Sci USA 2001;98:1267-1272.
35. Liao Z, Cimakasky LM, Hampton R, Nguyen DH, Hildreth JEK. Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1. AIDS Res Hum Retroviruses 2001;17:1009-1019.
36. Lin SH, Civelli O. Orphan G protein-coupled receptors: targets for new therapeutic interventions. Ann Med 2004;36:204-214.
37. Lingwood D, Simons K. Lipid rafts as a membrane-organizing principle. Science 2010;327:46-50.
38. Liscum L, Underwood KW. Intracellular cholesterol transport and compartmentation. J Biol Chem 1995;270:15443-15446.
39. Manes S, del Real G, Martinez-A C. Pathogens: raft hijackers. Nat Rev Immunol 2003;3: 557-568.
40. Menge T, Hartung H-P, Stuve O. Statins-a cure-all for the brain? Nat Rev Neurosci 2005;6:325-331.
41. Mouritsen OG. The liquid-ordered state comes of age. Biochim Biophys Acta 2010;1798: 1286-1288.
42. Mouritsen OG, Zuckermann MJ. What's so special about cholesterol? Lipids 2004;39: 1101-1113.
43. Mukherjee S, Maxfield FR. Membrane domains. Annu Rev Cell Dev Biol 2004;20: 839-866.
44. Oddi S, Dainese E, Fezza F, Lanuti M, Barcaroli D, De Laurenzi V, Centonze D, Maccarrone M. Functional characterization of putative cholesterol binding sequence (CRAC) in human type-1 cannabinoid receptor. J Neurochem 2011;116:858-865.
45. Paila YD, Chattopadhyay A. The function of G-protein coupled receptors and membrane cholesterol: specific or general interaction? Glycoconj J 2009;26:711-720.
46. Paila YD, Chattopadhyay A. Membrane cholesterol in the function and organization of G-protein coupled receptors. Subcell Biochem 2010;51:439-466.
47. Paila YD, Murty MRVS, Vairamani M, Chattopadhyay A. Signaling by the human serotonin1A receptor is impaired in cellular model of Smith-Lemli-Opitz Syndrome. Biochim Biophys Acta 2008;1778:1508-1516.
48. Paila YD, Pucadyil TJ, Chattopadhyay A. The cholesterol-complexing agent digitonin modulates ligand binding of the bovine hippocampal serotonin1A receptor. Mol Membr Biol 2005;22:241-249.
49. Paila YD, Tiwari S, Chattopadhyay A. Are specific nonannular cholesterol binding sites present in G-protein coupled receptors? Biochim Biophys Acta 2009;1788:295-302.
50. Paila YD, Tiwari S, Sengupta D, Chattopadhyay A. Molecular modeling of the human serotonin1A receptor: role of membrane cholesterol in ligand binding of the receptor. Mol Biosyst 2011;7:224-234.
51. Pandit SA, Jakobsson E, Scott HL. Simulation of the early stages of nano domain formation in mixed bilayers of sphingomyelin, cholesterol, and dioleylphosphatidylcholine. Biophys J 2004;87:3312-3322.
52. Papakostas GI, Ongür D, Iosifescu DV, Mischoulon D, Fava M. Cholesterol in mood and anxiety disorders: review of the literature and new hypotheses. Eur Neuropsychopharmacol 2004;14:135-142.
53. Peroutka SJ, Howell TA. The molecular evolution of G Protein-coupled receptors: focus on 5-hydroxytryptamine receptors. Neuropharmacology 1994;33:319-324.
54. Phillips R, Ursell T, Wiggins P, Sens P. Emerging roles for lipids in shaping membraneprotein function. Nature 2009;459:379-385.
55. Pierce KL, Premont RT, Lefkowitz RJ. Seven-transmembrane receptors. Nat Rev Mol Cell Biol 2002;3:639-650.
56. Porter FD, Herman GE. Malformation syndromes caused by disorders of cholesterol synthesis. J Lipid Res 2011;52:6-34.
57. Porter JA, Young KE, Beachy PA. Cholesterol modification of hedgehog signalling proteins in animal development. Science 1996;274:255-259.
58. Pucadyil TJ, Chattopadhyay A. Cholesterol modulates the ligand binding and G-protein coupling to serotonin1A receptors from bovine hippocampus. Biochim Biophys Acta 2004;1663:188-200.
59. Pucadyil TJ, Chattopadhyay A. Cholesterol modulates the antagonist-binding function of bovine hippocampal serotonin1A receptors. Biochim Biophys Acta 2005;1714:35-42.
60. Pucadyil TJ, Chattopadhyay A. Role of cholesterol in the function and organization of G-protein coupled receptors. Prog Lipid Res 2006;45:295-333.
61. Pucadyil TJ, Chattopadhyay A. Cholesterol depletion induces dynamic confinement of the G-protein coupled serotonin1A receptor in the plasma membrane of living cells. Biochim Biophys Acta 2007a;1768:655-668.
62. Pucadyil TJ, Chattopadhyay A. Cholesterol: a potential therapeutic target in Leishmania infection? Trends Parasitol 2007b;23:49-53.
63. Pucadyil TJ, Kalipatnapu S, Chattopadhyay A. The serotonin1A receptor: a representative member of the serotonin receptor family. Cell Mol Neurobiol 2005a;25:553-580.
64. Pucadyil TJ, Shrivastava S, Chattopadhyay A. Membrane cholesterol oxidation inhibits ligand binding function of hippocampal serotonin1A receptors. Biochem Biophys Res Commun 2005b;331:422-427.
65. Pucadyil TJ, Shrivastava S, Chattopadhyay A. The sterol-binding antibiotic nystatin differentially modulates ligand binding of the bovine hippocampal serotonin1A receptor. Biochem Biophys Res Commun 2004a;320:557-562.
66. Pucadyil TJ, Tewary P, Madhubala R, Chattopadhyay A. Cholesterol is required for Leishmania donovani infection: implications in leishmaniasis. Mol Biochem Parasitol 2004b;133:145-152.
67. Riethmüller J, Riehle A, Grassmé H, Gulbins E. Membrane rafts in host-pathogen interactions. Biochim Biophys Acta 2006;1758:2139-2147.
68. Rose IA, Hanson KR, Wilkinson KD, Wimmer MJ. A suggestion for naming faces of ring compounds. Proc Natl Acad Sci USA 1980;77:2439-2441.
69. Rosenbaum DM, Rasmussen SGF, Kobilka BK. The structure and function of G proteincoupled receptors. Nature 2009;459:356-363.
70. Saxena R, Chattopadhyay A. Membrane organization and dynamics of the serotonin1A receptor in live cells. J Neurochem 2011;116:726-733.
71. Scolari S, Müller K, Bittman R, Herrmann A, Müller P. Interaction of mammalian seminal plasma protein PDC-109 with cholesterol: implications for a putative CRAC domain. Biochemistry 2010;49:9027-9031.
72. Shin J-S, Abraham SN. Caveolae as portals of entry for microbes. Microbes Infect 2001;3:755-761.
73. Shrivastava S, Paila YD, Dutta A, Chattopadhyay A. Differential effects of cholesterol and its immediate biosynthetic precursors on membrane organization. Biochemistry 2008;47:5668-5677.
74. Shrivastava S, Pucadyil TJ, Paila YD, Ganguly S, Chattopadhyay A. Chronic cholesterol depletion using statin impairs the function and dynamics of human serotonin1A receptors. Biochemistry 2010;49:5426-5435.
75. Simons K, Ehehalt R. Cholesterol, lipid rafts, and disease. J Clin Invest 2002;110: 597-603.
76. Simons K, Ikonen E. How cells handle cholesterol. Science 2000;290:1721-1725.
77. Simons K, van Meer G. Lipid sorting in epithelial cells. Biochemistry 1988;27: 6197-6202.
78. Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 2000;1:31-39.
79. Singh P, Paila YD, Chattopadhyay A. Differential effects of cholesterol and 7-dehydrocholesterol on the ligand binding activity of the hippocampal serotonin1A receptors: implications in SLOS. Biochem Biophys Res Commun 2007;358:495-499.
80. van der Goot FG, Harder T. Raft membrane domains: from a liquid-ordered membrane phase to a site of pathogen attack. Semin Immunol 2001;13:89-97.
81. van der Meer-Janssen YPM, van Galen J, Batenburg JJ, Helms JB. Lipids in host-pathogen interactions: pathogens exploit the complexity of the host cell lipidome. Prog Lipid Res 2010;49:1-26.
82. Villalaín J. Location of cholesterol in model membranes by magic-angle-sample-spinning NMR. Eur J Biochem 1996;241:586-593.
83. Vincenta N, Genina C, Malvoisina E. Identification of a conserved domain of the HIV-1 transmembrane protein gp41 which interacts with cholesteryl groups. Biochim Biophys Acta 2002;1567:157-164.
84. Wolf C, Chevy F, Pham J, Kolf-Clauw M, Citadelle D, Mulliez N, Roux C. Changes in serum sterols of rats treated with 7-dehydrocholesterol-Δ7-reductase inhibitors: comparison to levels in humans with Smith-Lemli-Opitz syndrome. J Lipid Res 1996;37:1325-1333.
85. Xu X, London E. The effect of sterol structure on membrane lipid domains reveals how cholesterol can induce lipid domain formation. Biochemistry 2000;39:843-849.
86. Zhang Y, DeVries ME, Skolnick J. Structure modeling of all identified G protein-coupled receptors in the human genome. PLoS Comput Biol 2006;2:88-99.
87. Zidovetzki R, Levitan I. Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies. Biochim Biophys Acta 2007;1768:1311-1324.